BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 11319909)

  • 1. Suppression of colorectal cancer growth using an adenovirus vector expressing an antisense K-ras RNA.
    Nakano M; Aoki K; Matsumoto N; Ohnami S; Hatanaka K; Hibi T; Terada M; Yoshida T
    Mol Ther; 2001 Apr; 3(4):491-9. PubMed ID: 11319909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposome-mediated in vivo gene transfer of antisense K-ras construct inhibits pancreatic tumor dissemination in the murine peritoneal cavity.
    Aoki K; Yoshida T; Sugimura T; Terada M
    Cancer Res; 1995 Sep; 55(17):3810-6. PubMed ID: 7641198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of genes showing differential expression in antisense K-ras-transduced pancreatic cancer cells with suppressed tumorigenicity.
    Ohnami S; Matsumoto N; Nakano M; Aoki K; Nagasaki K; Sugimura T; Terada M; Yoshida T
    Cancer Res; 1999 Nov; 59(21):5565-71. PubMed ID: 10554036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraperitoneal injection of adenovirus expressing antisense K-ras RNA suppresses peritoneal dissemination of hamster syngeneic pancreatic cancer without systemic toxicity.
    Miura Y; Ohnami S; Yoshida K; Ohashi M; Nakano M; Ohnami S; Fukuhara M; Yanagi K; Matsushita A; Uchida E; Asaka M; Yoshida T; Aoki K
    Cancer Lett; 2005 Jan; 218(1):53-62. PubMed ID: 15639340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of Ki-ras p21 levels leading to growth inhibition of pancreatic cancer cell lines with Ki-ras mutation but not those without Ki-ras mutation.
    Aoki K; Yoshida T; Matsumoto N; Ide H; Sugimura T; Terada M
    Mol Carcinog; 1997 Oct; 20(2):251-8. PubMed ID: 9364215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-alpha and antisense K-ras RNA combination gene therapy against pancreatic cancer.
    Hatanaka K; Suzuki K; Miura Y; Yoshida K; Ohnami S; Kitade Y; Yoshida T; Aoki K
    J Gene Med; 2004 Oct; 6(10):1139-48. PubMed ID: 15452878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth inhibitory effect of anti-K-ras adenovirus on lung cancer cells.
    Alemany R; Ruan S; Kataoka M; Koch PE; Mukhopadhyay T; Cristiano RJ; Roth JA; Zhang WW
    Cancer Gene Ther; 1996; 3(5):296-301. PubMed ID: 8894248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-tumorigenic effect of a K-ras ribozyme against human lung cancer cell line heterotransplants in nude mice.
    Zhang YA; Nemunaitis J; Scanlon KJ; Tong AW
    Gene Ther; 2000 Dec; 7(23):2041-50. PubMed ID: 11175317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor activity of an oncolytic adenovirus-delivered oncogene small interfering RNA.
    Zhang YA; Nemunaitis J; Samuel SK; Chen P; Shen Y; Tong AW
    Cancer Res; 2006 Oct; 66(19):9736-43. PubMed ID: 17018633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting inhibition of K-ras enhances Ad.mda-7-induced growth suppression and apoptosis in mutant K-ras colorectal cancer cells.
    Lebedeva IV; Su ZZ; Emdad L; Kolomeyer A; Sarkar D; Kitada S; Waxman S; Reed JC; Fisher PB
    Oncogene; 2007 Feb; 26(5):733-44. PubMed ID: 16924242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ischemia-induced K-ras mutations in human colorectal cancer cells: role of microenvironmental regulation of MSH2 expression.
    Shahrzad S; Quayle L; Stone C; Plumb C; Shirasawa S; Rak JW; Coomber BL
    Cancer Res; 2005 Sep; 65(18):8134-41. PubMed ID: 16166287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The study of the effect of antisense oligonucleotide specific to K-ras point mutation on human pancreatic carcinoma cell PC-2].
    Wang YX; Gao L; Ji ZZ
    Zhonghua Wai Ke Za Zhi; 2005 Nov; 43(21):1387-90. PubMed ID: 16318775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenovirus-mediated anti-K-ras ribozyme induces apoptosis and growth suppression of human pancreatic carcinoma.
    Tsuchida T; Kijima H; Hori S; Oshika Y; Tokunaga T; Kawai K; Yamazaki H; Ueyama Y; Scanlon KJ; Tamaoki N; Nakamura M
    Cancer Gene Ther; 2000 Mar; 7(3):373-83. PubMed ID: 10766343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific inhibition of K-ras expression and tumorigenicity of lung cancer cells by antisense RNA.
    Mukhopadhyay T; Tainsky M; Cavender AC; Roth JA
    Cancer Res; 1991 Mar; 51(6):1744-8. PubMed ID: 1998965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ribozyme against mutant K-ras mRNA suppresses tumor growth of pancreatic cancer.
    Kijima H; Yamazaki H; Nakamura M; Scanlon KJ; Osamura RY; Ueyama Y
    Int J Oncol; 2004 Mar; 24(3):559-64. PubMed ID: 14767540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional targets of hepatocyte growth factor signaling and Ki-ras oncogene activation in colorectal cancer.
    Seiden-Long IM; Brown KR; Shih W; Wigle DA; Radulovich N; Jurisica I; Tsao MS
    Oncogene; 2006 Jan; 25(1):91-102. PubMed ID: 16158056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of orthotopic human lung cancer growth by intratracheal instillation of a retroviral antisense K-ras construct.
    Georges RN; Mukhopadhyay T; Zhang Y; Yen N; Roth JA
    Cancer Res; 1993 Apr; 53(8):1743-6. PubMed ID: 8467490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyamine depletion by ODC-AdoMetDC antisense adenovirus impairs human colorectal cancer growth and invasion in vitro and in vivo.
    Zhang B; Liu XX; Zhang Y; Jiang CY; Hu HY; Gong L; Liu M; Teng QS
    J Gene Med; 2006 Aug; 8(8):980-9. PubMed ID: 16783835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of growth inhibition of lung cancer cells by siRNA targeting mutant K-ras gene in vitro and in vivo].
    Zhang ZP; Jiang GC; Yang F; Zhou ZL; Wang J
    Zhonghua Wai Ke Za Zhi; 2007 Sep; 45(18):1267-70. PubMed ID: 18067742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A single recombinant adenovirus expressing p53 and p21-targeting artificial microRNAs efficiently induces apoptosis in human cancer cells.
    Idogawa M; Sasaki Y; Suzuki H; Mita H; Imai K; Shinomura Y; Tokino T
    Clin Cancer Res; 2009 Jun; 15(11):3725-32. PubMed ID: 19458054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.